Added to YB: 2017-04-19
Pitch date: 2017-04-19
NLNK [bullish]
NewLink Genetics Corporation
-89.11%
current return
Author Info
No bio for this author
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
As of March 18, 2020, NewLink Genetics Corporation was acquired by Lumos Pharma, Inc., in a reverse merger transaction.
Market Cap
$33.2M
Pitch Price
$73.53
Price Target
N/A
Dividend
N/A
EV/EBITDA
N/A
P/E
-0.77
EV/Sales
N/A
Sector
Biotechnology
Category
N/A
Show full summary:
NewLink Genetics Corp. NLNK
A summary for this pitch has not been created yet.
Read full article (0 min)